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Abstract
Background: To examine the potential improvement in treatment planning for patients with skull base
meningioma using IMRT compared to carbon ion or proton beams with and without a gantry.
Methods: Five patients originally treated with photon IMRT were selected for the study. Ion beams were chosen
using a horizontal beam or an ion gantry. Intensity controlled raster scanning and the intensity modulated particle
therapy mode were used for plan optimization. The evaluation included analysis of dose-volume histograms of the
target volumes and organs at risk.
Results: In comparison with carbon and proton beams only with horizontal beams, carbon ion treatment plans
could spare the OARs more and concentrated on the target volumes more than proton and photon IMRT
treatment plans. Using only a horizontal fixed beam, satisfactory plans could be achieved for skull base tumors.
Conclusion: The results of the case studies showed that using IMPT has the potential to overcome the lack of a
gantry for skull base tumors. Carbon ion plans offered slightly better dose distributions than proton plans, but the
differences were not clinically significant with established dose prescription concepts.
Keywords: Plan comparison, Photon IMRT, Carbon ions, Protons, Gantry
Introduction
Treatment of skull base tumors is a challenge for the
radiation oncologist. Optimization of dose distributions
to complex target volumes has been a main goal over
the last decades, and modern photon techniques such as
Intensity Modulated Radiotherapy (IMRT) have signifi-
cantly improved treatment of base of skull tumors. His-
tological subtypes in the skull base region include highly
malignant tumors such as high-grade hemangiopericyto-
mas, squamous cell carcinomas or sarcomas, but also
benign lesions, such as meningiomas. In these patients,
high local doses for tumor control are also required,
however, also sparing of normal tissue to prevent treat-
ment-related side effects impairing quality of life is of
high importance.
Several publications reported comparison studies in
the head and neck region and the central nervous sys-
tem using proton or carbon ion therapy as well as con-
ventional and/or IMRT [1-8]. In photon treatments, a
gantry is standard today and is necessary to obtain good
dose distributions and conformity and to avoid high
doses to organs at risk (OAR). IMRT can create distri-
butions with higher concentration to be desired target
volumes and to spare OARs. Several comparative studies
using protons or ions showed a potential superiority
over photons, especially for larger target volumes [6].
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any medium, provided the original work is properly cited.This is mostly due to the distinct characteristics of par-
ticle beams: Particle therapy has physical advantages
with a sharp increase of dose in a well-defined depth
(Bragg peak) and a rapid dose falloff beyond that
maximum.
Protons have been used for treatment of meningiomas.
Combined proton and photon radiotherapy was pub-
lished from several institutions [9-12].
Experience with carbon ion radiotherapy has been
acquired in the past mainly using horizontal beam lines.
Excellent dose distributions can be achieved for numer-
ous clinical cases using only horizontal beams. However
the freedom to apply the beam on a gantry that rotates
around the patient is expected to offer significant advan-
tages, especially for certain anatomical regions, such as
gastrointestinal tumors, paraspinal tumors, but also skull
base lesions, as pointed out in Jäkel and Debus [13].
There is an extreme variation of density in these areas.
These heterogeneities affect the energy distribution in
the beam, e.g. a bone, decreases the particle’s physical
range as an air cavity extends the physical range as com-
pared to water [14]. One of the advantages of a gantry is
that it is possible to choose beam angles which pass
through more homogeneous tissue, thus avoiding or
reducing range uncertainties.
The Heidelberg Ion Therapy Center (HIT) started
clinical operation in November 2009. At HIT, 3 treat-
ment rooms, two with a horizontal fixed beam and one
with a carbon ion and proton gantry, are available for
treatment.
In the present study, we performed a comparative
planning study for complex skull base tumors focusing
on meningioma patients evaluating IMRT, protons and
carbon ions with and without a gantry in an institutional
“real-time szenario”. The IMPT mode is available at HIT
and we adopted this mode for the calculation. The focus
was put on evaluation of dose distributions, and DVH
analysis with special respect to OAR.
Materials and methods
Five patients originally treated with photon IMRT were
selected for this comparative study. All patients were
diagnosed with benign menigioma (Table 1). The mean
age of the patients at the start of photon IMRT was
58.4 years (range 39-81 years), 3 males and 2 females.
No patient had a history of former irradiation. IMRT
was applied with a linear accelerator (Siemens, Erlangen,
Germany) using the step-and-shoot technique in four
patients and with helical Tomotherapy in one patient.
Patients were immobilized in supine position with a
Scotch Cast™ (3 M, St. Paul MN, USA) mask system as
published previously [15,16]. CT scans were performed
for treatment planning with a 3-mm slice thickness. For
target volume definition, additional examinations such
as contrast-enhanced MRI (magnetic resonance ima-
ging) as well as 68 Ga-Dotatoc PET were used. For the
treatment plan comparison, ion beams were chosen
using a horizontal beam, or an ion gantry. Two different
optimization modes are available at HIT within the
treatment planning system. In the single beam optimiza-
tion mode, the beams are optimized independently
towards homogeneous dose distributions that, when
summed up, result in the desired distribution. Mean-
while all beams are optimized simultaneously in IMPT
m o d e .I nt h i ss t u d y ,t h eI M P Tm o d ew a su s e df o r
optimization.
Target volume definition for different techniques and
dose concepts
For benign meningiomas the gross tumor volume (GTV)
is defined as the macroscopically visible tumor on con-
trast-enhanced imaging; a clinical target volume (CTV)
of about 1-2 mm is added to allow for potential micro-
scopic spread. A planning target volume (PTV) is added
depending on the technique used and the known setup
inaccuracies, between 1-3 mm.
At HIT, we have established target volume and dosing
concepts for different radiation techniques depending
on the histology, the necessary clinical target volume,
the required dose and the beam quality. With photons,
skull base menigniomas are treated with total doses of
52.2-57.6 Gy depending on the size of the lesion and
the vicinity to OAR, in single doses of 1.8 Gy. Since
protons are associated with an overall comparable RBE,
the same dose and fractionation schemes are applied
with photons. For carbon ions, due to the reduced beam
broadening as well as the known higher RBE, slightly
hypofractionated regimens (with 3 Gy E single doses)
Table 1 Clinical features of five meningioma patients
Patient No. Sex Age
(years)
Tumor site Histopathology Target volume (cm
3)
1 Male 61 ethmoid sinus WHO I 76.62
2 Female 45 left skull base WHO I 54.7
3 Male 39 right skull base WHO I 77.4
4 Female 81 skull base - left temporal lobe WHO I 170.3
5 Male 66 left skull base WHO I 17.0
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based on the favourable clinical data obtained at GSI.
To compare plans in our “real time scenario”,t h e s e
dose and fractionation schedules were used in the pre-
sent analysis.
For target volume definition, PTV margins at HIT
include not only setup inaccuracy as for photons, but
also range uncertainties. For example, for skull base
tumors, commonly, a median PTV margin of 3 mm is
used in our institution for protons and carbon ions.
Treatment plans and delivery
Figure 1 shows an example for the examinations used
for treatment planning showing Case 2. Contouring of
target volumes and OARs for particle therapy planning
was performed with the Siemens Dosimetrist and
Oncologist software (Siemens, Erlangen, Germany). On
the other hand, photon IMRT treatments were carried
out with two different treatment machines. Calculations
for photon IMRT were based on inverse treatment plan-
ning with the Hi-ART Tomotherapy planning station
version 2.2.1.55 (Tomotherapy Incorporated, Madison,
WI, USA) and the Konrad System version 2.2.23 (Sie-
mens, Erlangen, Germany). 6-MV photon beams were
used for both plans. IMRT treatment planning was per-
formed on the basis of an isocentric eight to nine-beam
arrangement, with Konrad in the step-and-shoot
technique.
The Treatment Planning System for particle therapy
was performed by a commercial treatment planning sys-
tem Syngo PT Planning (Siemens, Erlangen, Germany).
Plan calculation was based on the treatment planning
CT without contrast enhancement. For the OARs con-
sidered in this comparison study, the tolerance levels
were based on the work of Emami et al [17]. The doses
to OARs were set below maximum 60 Gy for the brain-
stem; 50 Gy for the optic chiasm; 50 Gy for the optic
nerves; 45 Gy for the optic globe; 10 Gy for the lens; 32
Gy for the parotid gland. To compare these results
directly, target structures and OARs contoured for the
original photon IMRT plans were used also for the par-
ticle therapy plans. Two to three coplanar or
noncoplanar beams were used for particle therapy treat-
ment. The gantry rotation was not restricted in both
coplanar and noncoplanar setup, but the treatment table
was restricted to a range between 10 and 170 degrees
within the provided software due to collision of the hor-
izontal beam nozzle with the table. The couch and gan-
t r ya n g l e so fp a r t i c l et h e r a p yp l a n sw e r ed e s i g n e d
according to the restriction (Table 2). The maximum
field size for both proton and carbon ion therapy at
HIT is 20 by 20 cm. The pencil beams chosen for this
study typically have a lateral full-width-at-half-maximum
(FWHM) of 6 mm for carbon ion and 10 mm for pro-
ton treatment plans.
Prescribed dose for original treatment planning with
photon IMRT was tailored according to age, tumor
volume and tumor location. Prescription dose for pro-
tons varied from 53.65 to 57.66 GyE (1.8 GyE to 1.86
GyE/Fr) since all patients were diagnosed benign menin-
giomas and there have been reports of good control of
benign meningiomas with proton ion therapy [10,18,19].
H o w e v e rc a r b o ni o nt h e r a p ym a yp l a yag r e a tr o l ei n
treating high risk meningiomas [20]. Based on our clini-
cal concept for carbon ion treatments with the aim to
perform a comparison in a “real time szenario“, all car-
bon plans were prescribed at 60 GyE/20Fr (3 GyE/Fr;
T a b l e3 ) .T h et a r g e tv o l u m ew a se n c o m p a s s e db yt h e
95% isodose line in principle, but some areas where
were adjacent to OARs were covered with 90% isodose
line. However 90% and 95% isodose lines are very close
in particle therapy plans.
Evaluation tools
The evaluation included analysis of dose-volume histo-
grams of the target volumes and organs at risk. For each
patient and each organ, a set of physical parameters was
computed from the DVHs to assess the general charac-
teristics of different techniques. The same dose con-
straints were adopted for optimization of the same
patient’s plan. Plans were also assessed by visual inspec-
tion of dose distributions.
Results
Each patient was analyzed individually. PTV size data
for each patient are reported in Table 1. The mean
volume was 79.2 cm
3, median 76.6 cm
3, minimum 17.0
cm
3, and maximum 170.3 cm
3.
Dose distributions and dose volume histograms for each
case
Figure 2 shows axial slices for photon IMRT, carbon ion
and proton plans for Case 1. Figure 3 shows cumulative
dose volume histograms for the PTV, brain stem, right
lens, right optic nerve and left eye (given as a percentage
of the prescribed target dose). The tumor was located at
Figure 1 An example of the pretreatment pictures. (A) CT with
contrast enhancement, (B) MRI with contrast enhancement and (C)
68 Ga-DOTATOC-PET for Case 2.
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The IMRT plan was made with Tomotherapy and three
beams were used for carbon ion and proton plan only
with horizontal beams. Table 4 demonstrates the results
of Vx which were computed from the DVH curves to
compare the characteristics of photon IMRT, carbon ion
and proton. Vx corresponds to the fractional volume
irradiated to a percentage dose higher than x% [8].
Tomotherapy and carbon ion radiotherapy were super-
ior to proton therapy regarding circumvention of both
eye lenses. This is solely due to the horizontal beam
direction chosen for proton and ion beams. Both parti-
cle therapies allowed a nearly complete avoidance of the
brain stem as opposed to Tomotherapy which irradiated
the brain stem with about 10-30% of the dose. The
results of the DVH curves also demonstrated the results
of the visual inspections. The curves of the PTV were
nearly the same in all three radiotherapies. The right
lens was well spared using Tomotherapy and carbon ion
radiotherapy. The sparing of the brain stem was
achieved only at high doses in the case of Tomotherapy,
but also for low doses with proton therapy and complete
sparing was achieved with carbon therapy.
The tumor locations of Case 2 and Case 3 were simi-
lar. Both meningiomas were attached to brain stem, one
located on the left side of the brain stem and the other
located on the right side of the brain stem. The
resulting dose distributions of proton plans and photon
IMRT plans for Case 2 are shown in Figure 4. They
included at least one of the optic nerves. As the is
tumor located one-sided, two beams were chosen from
t h es a m es i d eo ft h et u m o ru s i n gp r o t o n s .A tt h ec o m -
parison of the dose-volume histograms between a gantry
plan and a plan with horizontal beams, a gantry plan
showed better dose sparing for some organs at risk in
Case 2, but the differences were small. The dose-volume
histograms for the OARs for Case 3 were almost com-
parable. The merit of a gantry for these cases was that
we could choose beam angles avoiding air-filled cavities.
These areas usually lead to substantial range uncertain-
ties. For example, in the plan of Figure 4(B), both beams
came from the left side and they were delivered with
horizontal fixed beams. The effect of the air filled cavity
leading to possible over- or under-shoot would appear
around the brain stem. On the other hand, two beams
came from left side but they were a little tilted to the
anterior and posterior side using a gantry in Figure 4
(C). One beam from the posterior side passed through
the air filled cavity but possible overshoot would
appear around the sphenoidal sinus area and not
within the brain stem region. The PTV of Case 4 was
170.3 cm
3 and tumor was extended widely into the left
eye area. It also included both optic nerves and a part
of the left retina. Because the target was relatively
large, it was difficult to place beams three dimension-
ally to cover this PTV while avoiding OARs at the
same time. In this case, plans only with horizontal
Table 2 Couch and gantry angles for patients
Patient
No.
original photon IMRT carbon/proton ion horizontal
plan
proton gantry plan
1 helical Tomotherapy (8, 90) (172, 90) (272, 90) none
2 8 beam IMRT (8, 90) (330, 90) (8, 70) (8, 120)
3 8 beam IMRT (172, 90) (210, 90) (355, 240) (355, 270)
4 8 beam IMRT (8,90) (335, 90) none
5 8 beam IMRT (8,90) (172, 90) (320, 90) (0,150) (0, 305) (270, 60)
Case 2-5 were treated with a linear accelerator using step and shoot technique. (x, y) shows (couch angle, gantry angle)
Table 3 Dose prescripition for patients (original dose,
proton dose, carbon ion dose)
Patient
No.
original photon
IMRT
carbon ion plan proton plan
total
dose
fraction total
dose
fraction total
dose
fraction
1 57.6 GyE 32 Fr 60 GyE 20 Fr 57.6 GyE 32 Fr
2 57.66
GyE
31 Fr 60 GyE 20 Fr 57.66
GyE
31 Fr
3 57.66
GyE
31 Fr 60 GyE 20 Fr 57.66
GyE
31 Fr
4 53.94
GyE
29 Fr 60 GyE 20 Fr 53.94
GyE
29 Fr
5 53.65
GyE
29 Fr 60 GyE 20 Fr 53.65
GyE
29 Fr
Figure 2 Dose distribution in transverse plane for (A) photon
IMRT, (B) carbon ion and (C) proton treatment planning
techniques. The same beam arrangements were used for carbon
ion and proton plans. These plans consisted of two lateral beams
and one cranial beam.
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particle therapy treatment. The dose-volume histogram
curves of the PTV were nearly the same in all three
radiotherapy szenarios in this case. In comparison with
carbon and proton beams only with horizontal beams,
the carbon ion treatment plan could spare the OAR
much more compared to proton and photon IMRT
treatment plans.
Figure 3 Cumulative dose volume histograms for PTV, right lens, right optic nerve, brainstem and left eye for one Case 1 (given as a
percentage of the prescribed target dose).
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(17 cm
3), it was adjacent to the brain stem but separated
from other organs at risk. Therefore the brain stem was
paid the most attention in this case. Demonstration
plans were made to examine whether using a gantry had
a benefit for proton planning. Figure 5 showed the dose
distributions of three different plans for Case 5. We
employed two beams for particle radiotherapy plans.
One beam was placed in order to avoid the mastoid
antrum which contains air. The other beam was placed
on the cranial side. The photon IMRT plan was
designed with nine beams. The PTV curves of three
plans were almost the same. It was difficult to observe
advantages of the gantry from the result of the dose-
volume histograms in this case, as shown in Table 5.
One advantage with a gantry was that it was easier to
place beams to spare the mastoid antrum. IMRT plans
were optimal, and were hardly improved by ion beams
in this case.
Discussion
In the present work we compared treatment planning
using IMRT, protons and carbon ions for complex-
shaped menigiomas in the skull base region. In most
cases, IMRT provided excellent dose distributions, and
only for certain OAR particle therapy showed a substan-
tial benefit. Even for complex shapes a gantry was not
essential in most cases. However, to avoid air-filled cav-
ities in some clinical situations to reduce uncertainties,
beam angles provided by a gantry are most likely to be
highly superior. A quantitative analysis of the robustness
of the treatment plans against these effects was beyond
the scope of this work.
Compared to other intracranial tumors, skull base
meningiomas often have complex shapes [21-27]. Parti-
cle therapy may be offered to patients with meniningio-
mas, especially as they are characterized by long-term
survival, and minimization of treatment related side
effects is of high importance, including neurocognitive
sequelae [18-20,28]. Therefore, increasing dose conform-
ality and reducing dose to normal tissue is of high
importance. Particle therapy could offer highly confor-
mal irradiation for complex-shaped intracranial menin-
giomas, since it is characterized by excellent dose
conformity. In this study, two comparisons were exam-
ined. First, original photon plans and demonstration
plans using proton and carbon ion were compared. Sec-
ond, these comparison plans were made as well to
examine the benefits of a gantry when skull base tumors
were treated with particle therapy. Comparisons were
carried out in terms of physical parameters derived from
3D dose distributions and DVH calculations. Since the
aim of the study was to provide some rationaly as to
which patients clearly benefit from a gantry as opposed
to a horizontal beam (since at HIT, both possibilities are
available) a “real-time-szenario” was chosen respecting
the institutional dose and fractionation schemes for
photons, protons and carbon ions. For example, due to
the biological and physical characteristics of the carbon
beam, carbon ions are applied with 3 Gy E single doses
in our institution [20]. This includes not only dose and
fractionation schemes, but also dose constraints and
dose-volume-parameters used for treatment plan
optimization.
Table 4 Results of the dose distribution for the PTV and
OARs of case 1
Organ Parameter photon IMRT
(%)
carbon ion
(%)
proton
(%)
PTV V90 99.9 100.0 99.6
Right lens V10 4.8 22.0 32.8
Right optic
nerve
V60 100.0 73.2 83.1
Brainstem V40 19.9 0 0
Left eye V40 46.6 18.4 22.3
Vx (corresponding to the fractional volume irradiated to a percentage dose
higher than x%)
Figure 4 Dose distributions for (A) photon IMRT plan, (B)
proton plan with horizontal beams, (C) proton plan with
gantry beams.
Figure 5 Dose distributions for (A) photon IMRT plan, (B)
proton plan with horizontal beams, (C) proton plan with
gantry beams.
Table 5 Results of the dose distribution for the PTV and
OAR of case 5
Organ Parameter photon IMRT
(%)
gantry plan
(%)
horizontal plan
(%)
PTV V90 97.2 98.5 98.8
Brainstem V40 25.6 20.5 21.4
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methods were used and the IMPT mode was used for
optimization. From a physical point of view, carbon ions
show a sharper Bragg peak and less lateral scattering
than protons, but also a significant dose in the fragmen-
tation tail behind the peak [29]. In our comparison
study, carbon ion plans could achieve better conforma-
tion of the dose to the target volumes than proton plans
especially in the high dose areas and better sparing of
dose to most of the organs at risk. But the differences
were small and proton plans resulted in better sparing
of some of the organs at risk as compared to photon
IMRT. Concerning the additional improvement of dose
concentration using carbon ions, however, there is no
clear picture. Carbon beams show a higher dose behind
the target because of the fragmentation tail. Therefore
the low dose area around 30% isodose for carbon ions
plans is larger in the distal region than for proton plans.
Photon IMRT could also spare some organs at risk well
in some cases, but the low-dose area in the photon
IMRT plans were obviously much larger than in particle
therapy plans. It should be kept in mind, however, that
an additional benefit from carbon ions which is
expected due to their radiobiological properties is not
displayed in the treatment plan. E.g. a higher RBE is
expected in the tumor as compared to the normal tis-
sue, but a fixed RBE table is currently used for all tis-
sues in the TPS. Additionally, is should be kept in mind
that differences in pencil beam size can potentially con-
tribute to differences in the treatment plan differences
between ions themselves, but also compared to photons.
Baumert et al. reported that protons were generally
better than photons at sparing dose to the OAR which
w a sc l o s et ot h et a r g e t .B u tw h e nt h e yu s e do n l yt w o
fields to one patient, protons showed higher doses to
surrounding OARs. A higher number of fields may
result in a better conformity [5]. It was also experienced
in our study. Compared to photon IMRT, small num-
bers of beams are employed for particle therapy. That
means one beam has a big influence on the dose distri-
bution and beam arrangements are very important. In
making demonstration plans, we avoided to use an ante-
rior beam to spare dose from sensitive OARs such as
the eyes. Additionally an anterior field would have to
pass through the oral cavity which poses large problems
for proton and carbon ion calculations due to the large
variability of position and interfaces between materials
with large density differences.
The calculation results showed that the OARs which
were far from targets were irradiated with lower mean
doses in particle therapy than in photon IMRT. For the
maximum dose, some cases showed higher doses in par-
ticle plans than in photon plans, possibly due to the use
of only two or three radiation fields. Depending on the
tumor location, even a third beam was not necessary.
Lomax et al. performed a comparison study between
IMRT and proton radiotherapy and nine beams were
employed to compare the plans [2]. They used the iden-
tical beam geometry, dose constraints, importance fac-
tor, but changed dose-volume constraints depending on
the plans. In this study, they reported the use of nine
proton fields could well be sub-optimal in paranasal
s i n u sa r e at u m o r ,a n dt h eu s eo fas m a l l e rn u m b e ro f
well chosen fields could achieve a similar level of target
coverage and sparing of critical structures.
For facilities equipped with gantries, planning for
dose delivery of protons and for carbon ions therapy
has the same degrees of freedom as for the photon
therapy. The aim of our study was to evaluate which
cases are relatively easily accessible with horizontal
fixed beam, and in which cases a gantry is really bene-
ficial. In this study, the advantage of a gantry is not
obvious. The first reason may be that most of the
tumor shapes were irregular and complex and even if
the gantry was used, it was difficult to find beam
arrangements avoiding organs at risk while fully irra-
diating the target volumes at the same time. The sec-
ond reason is probably that the IMPT optimization
mode was adopted. IMPT plans can be delivered using
the spot scanning system at HIT. Before making IMPT
plans, we made demonstration plans with the single
beam optimization (SBO) mode. Compared with these
two different modes, the results were apparently better
using IMPT mode than SBO mode. IMPT mode could
improve the conformity inside the target volumes and
spare the organs at risk which were in the vicinity of
the tumors. Mizumoto et al. have reported the results
of the three patients’ treatment plans using non-copla-
nar beams in Tsukuba, Japan [30]. They concluded
that non-coplanar proton beam therapy has advantages
in selected patients. If the tumor extends mainly along
the beam direction, the advantage of the gantry beams
would be significant. The major difference of our study
as compared to [30] is the treatment delivery system.
The proton facility in Tsukuba used passive beam
delivery, while HIT adopts active spot scanning beam
delivery. In active beam delivery, the energy of the
incoming beam is varied during the treatment [31].
Consequently IMPT can be accomplished. Because of
the IMPT mode, it was considered that the advantage
of the gantry with active methods seemed to be less
than with passive methods.T h er e s u l t si nt h i ss t u d y
showed that clinically satisfactory plans could be
achieved by means of a horizontal beam line for skull
base tumors with IMPT optimization [32] and a gantry
does not lead to a clinically significant improvement in
most cases. The role of uncertainties for both options
is, however, not clear yet. That is to say, the IMPT
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gantry for patients with skull base tumors.
Conclusion
This study attempted to explore the differences of dose
distribution between carbon ions and protons compared
to photons in an institutional “real-time szenario”. Com-
pared to photon IMRT, only marginal improvements
may be seen at the required doses and dose distribu-
tions. For tumors requiring even higher doses, the addi-
tional benefit of a particle beam may be much greater,
due to the reduction of integral dose. We also attempted
to analyse the potential benefit of the gantry for skull
base meningiomas. In the analysis of these five cases,
carbon ion plans showed better dose conformation to
the target volumes and sparing of OAR than proton
plans in most of the cases. These differences were small
and the advantage of carbon ions compared with pro-
tons is not always obvious. However, this work implied
that the IMPT mode may offer treatment plans with
improved quality for skull base tumors even if the facil-
ity doesn’t have a gantry. This finding is likely to change
for tumors located in the trunk of the body, e.g. gastro-
intestinal tumors or paraspinal tumors, where the access
through highly sensitive OAR in combination with dee-
ply located target volumes with horizontal beams may
be much more difficult.
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